BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 11928822)

  • 1. The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility.
    Kjøller L
    Biol Chem; 2002 Jan; 383(1):5-19. PubMed ID: 11928822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM; Chavakis T; Al-Fakhri N; Hersemeyer K; Monard D; Preissner KT
    J Cell Sci; 2004 Jan; 117(Pt 3):477-85. PubMed ID: 14679304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uPA receptor and the somatomedin B region of vitronectin direct the localization of uPA to focal adhesions in microvessel endothelial cells.
    Salasznyk RM; Zappala M; Zheng M; Yu L; Wilkins-Port C; McKeown-Longo PJ
    Matrix Biol; 2007 Jun; 26(5):359-70. PubMed ID: 17344041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin inhibits highly invasive prostate cancer cells.
    Lloyd FP; Slivova V; Valachovicova T; Sliva D
    Int J Oncol; 2003 Nov; 23(5):1277-83. PubMed ID: 14532966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
    J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.
    Madsen CD; Sidenius N
    Eur J Cell Biol; 2008 Sep; 87(8-9):617-29. PubMed ID: 18353489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease crosstalk with integrins: the urokinase receptor paradigm.
    Chapman HA; Wei Y
    Thromb Haemost; 2001 Jul; 86(1):124-9. PubMed ID: 11486997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin.
    Kjøller L; Hall A
    J Cell Biol; 2001 Mar; 152(6):1145-57. PubMed ID: 11257116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cell migration on vitronectin: regulation by components of the plasminogen activation system.
    Stahl A; Mueller BM
    Int J Cancer; 1997 Mar; 71(1):116-22. PubMed ID: 9096674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T; Kanse SM; May AE; Preissner KT
    Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.
    Behrendt N
    Biol Chem; 2004 Feb; 385(2):103-36. PubMed ID: 15101555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of different forms of the murine urokinase plasminogen activator receptor on the cell surface using monoclonal antibodies.
    Rasch MG; Pass J; Illemann M; Høyer-Hansen G; Lund IK
    J Immunol Methods; 2008 Nov; 339(1):55-65. PubMed ID: 18761343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U; Magdolen V; Hapke S; Schmitt M
    Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE; Saunders DN; Ranson M
    Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase plasminogen activator system: a multifunctional role in tumor progression and metastasis.
    Choong PF; Nadesapillai AP
    Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S46-58. PubMed ID: 14600592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urokinase plasminogen activator receptor (CD87): something old, something new.
    Ge Y; Elghetany MT
    Lab Hematol; 2003; 9(2):67-71. PubMed ID: 12828301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of urokinase-type plasminogen activator and its receptor in keloids.
    Leake D; Doerr TD; Scott G
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1334-8. PubMed ID: 14676162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
    Binder BR; Mihaly J; Prager GW
    Thromb Haemost; 2007 Mar; 97(3):336-42. PubMed ID: 17334498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.